Cases & Deals

Shanghai Junshi Biosciences completes $329 million placing of new H Shares on main board of The Stock Exchange of Hong Kong Limited

Clients Shanghai Junshi Biosciences Co., Ltd.

Jones Day advised Shanghai Junshi Biosciences Co., Ltd. (the “Company”), a company listed on the main board of The Stock Exchange of Hong Kong Limited and the STAR Market of the Shanghai Stock Exchange, in connection with its US$329 million placing of new H Shares of the Company.

Shanghai Junshi Biosciences Co., Ltd. is an innovation-driven biopharmaceutical company which is dedicated to the discovery and development of innovative drugs and their clinical research and commercialization on a global scale.